AttaCH: A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents with Achondroplasia
Details
Age
Child
Eligibility
Children and Adolescents who have completed a prior TransCon CNP trial.
Type of Study
Treatment
Scope
National
Locations
Childrens Hospital Colorado
Principal Investigator
Klane White, MD, MSc
Study ID
Protocol Number: 23-0807
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers